KevinNelsonHellerMD

Pediatric Hematology/Oncology

Executive Vice President, Research and Development

Dr. Heller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

George Washington University School of Medicine and Health SciencesClass of 1998

PubMed

829 citations
Ipilimumab in patients with melanoma and brain metastases: An open-label, phase 2 trial
Kim Margolin, Marc S. Ernstoff, Omid Hamid, Donald P. Lawrence, David F. McDermott
The Lancet. Oncology. 2012-05-01
30 citations
Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy.
Heller Kn, Teruya-Feldstein J, La Quaglia Mp, Wexler Lh
Journal of Pediatric Hematology/oncology. 2004-02-01
103 citations
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials
Jedd D. Wolchok, Jeffrey S. Weber, Omid Hamid, Céleste Lebbé, Michele Maio
Cancer Immunity. 2010-01-01

Jasper Therapeutics Announces New Clinical Trial with the National Institute of Allergy and Infectious Diseases to Evaluate JSP191 in Chronic Granulomatous DiseaseMay 26th, 2021
Making Stem Cell Transplants SaferApril 18th, 2021

Ebv-Specific T-Cells In Healthy Individuals And In Patients With EBV AssociatedNational Center For Research Resources2005
Ebv-Specific T-Cells In Healthy Individuals And EBVNational Center For Research Resources2004